Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Ponatinib With Chemotherapy for Young Adults With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT02776605 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT02776605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02776605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Ponatinib With Chemotherapy for Young Adults With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Lead sponsor
PETHEMA Foundation
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2016
Completion date
August 31, 2023
Enrollment
30 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

all